Acrobiosystems Co.,Ltd. (SHE:301080)
China · Delayed Price · Currency is CNY 41.41
+1.28 (3.19%)
At close: Jun 23, 2026
Acrobiosystems Stock Forecast
Stock Price Forecast
According to 6 analysts polled by S&P Global, Acrobiosystems stock has a consensus rating of "Strong Buy" and an average price target of ¥72.71. The average 1-year stock price forecast is 75.59% higher than the current stock price, while the lowest is ¥64.05 (+54.67%) and the highest is ¥80.00 (+93.19%).
Price Target: ¥72.71 (+75.59%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Acrobiosystems stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 6 | 6 | 6 | 5 | 5 | 5 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 7 | 7 | 7 | 6 | 6 | 6 |
Financial Forecast
Revenue This Year
1.07B
from 838.12M
Increased by 27.37%
Revenue Next Year
1.32B
from 1.07B
Increased by 23.60%
EPS This Year
1.77
EPS Next Year
2.50
from 1.77
Increased by 41.24%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is CNY.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 1.1B | ||
| Avg | 1.1B | ||
| Low | 1.1B |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 28.3% | ||
| Avg | 27.4% | ||
| Low | 26.4% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | ||
| Avg | 1.77 | ||
| Low | - |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | ||
| Avg | 111.8% | ||
| Low | - |